cialis with priligy 4, 113 For patients treated with bortezomib based therapy, the lack of a hematologic response after 2 cycles is usually a signal to change therapy and, in most cases, bortezomib and dexamethasone will be retained but other agents such as melphalan or immune modulatory drugs are added